In a 14-month follow-up, Sana…
In a 14-month follow-up, Sana Biotechnology has found that its [...]
Inovio Pharmaceuticals has laid…
Inovio Pharmaceuticals has laid off staff and prioritized programs to [...]
Immutep and the Australian…
Immutep and the Australian biotech’s investors have been caught off [...]
Artificial intelligence (AI) now…
Artificial intelligence (AI) now features prominently in boardroom and executive [...]
As pharmas like Eli Lilly and…
As pharmas like Eli Lilly and Roche bolster their biotech [...]
Vistagen Therapeutics is doubling…
Vistagen Therapeutics is doubling down on its lead social anxiety [...]
Evotec has escalated its already…
Evotec has escalated its already substantial reorganization, plotting an additional [...]
With a fresh leadership team…
With a fresh leadership team settling in, CNS Pharmaceuticals is [...]
Salspera has set out plans for a…
Salspera has set out plans for a $91 million IPO [...]
Less than a week after Roche…
Less than a week after Roche pledged a hefty investment [...]